PinCell
AcquiredInnovation in dermatology
Italy · $1.8M raised
- Employees
- 1–10
- Business Model
- B2B
- Website
- pincell.it
- Total Funding
- $1.8M
- Last Round
- $1.8M SeedMay 2021
- Rounds
- 1
- Acquisition Date
- Mar 2025
About
PinCell is a pre-clinical stage biotechnology company based in Italy focused on the development of novel anti-inflammatory therapies for rare and severe dermatological diseases with high unmet medical need. The company targets novel pathological pathways to develop first-in-class treatments for orphan skin diseases, leveraging the expertise of co-founder and CMO Professor Carlo Pincelli.
Summary
PinCell is a Biotech company based in Italy. It has raised $1.8M in total across 1 round, most recently a $1.8M Seed round in May 2021. Investors include Sofinnova Partners.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2025
Sign up to see all 2 rounds
Seed through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/pincell"><img src="https://indexed.vc/api/badge/company/pincell" alt="PinCell on Indexed.vc" width="260" height="76" /></a>